文献速递技术与安全胸部腹部PETCT

68Ga-FAPI摄取良性病变的回顾性研究

Benign lesions with 68Ga-FAPI uptake: a retrospective study.
PubMed 文献 · Br J Radiol · 2023-02-14

该回顾性研究分析了44例经病理或长期随访证实的FAPI阳性良性病变患者的68Ga-FAPI PET/CT影像,发现良性病变可累及肝、胰尾、胃、肺、淋巴结等多个系统,且各系统间SUVmax和TBR无显著差异,提示需注意将FAPI摄取的良性病变与恶性肿瘤鉴别。

要点

  • FAPI PET/CT中良性病变也可表现为摄取增高,阅片时需警惕假阳性。
  • 良性病变累及系统广泛,包括肺、肝、胰腺、淋巴结、肾、骨等。
  • 不同系统良性病变的SUVmax和TBR无显著差异,不能仅凭摄取程度鉴别。

关键影像表现/征象

  • 良性病变累及八个系统,包括肝(n=3)、胰尾(n=3)、胃(n=3)、食管(n=1)、肺(n=14)、纵隔(n=2)、鼻窦(n=1)、脑(n=2)、淋巴结(n=5)、肾(n=4)、骨(n=2)、肌肉(n=1)、甲状腺(n=1)、甲状旁腺(n=1)和乳腺(n=1)。

诊断标准与关键数值

  • 八个系统良性病变的平均SUVmax差异无统计学意义(p=0.471)。
  • 八个系统良性病变的平均TBR差异无统计学意义(p=0.830)。

临床应用与阅片要点

  • 在日常阅片和报告中,遇到FAPI摄取病灶时需结合形态、部位及临床信息鉴别良性病变,避免误判为恶性。
  • 对于肺、淋巴结等常见部位的FAPI高摄取,应考虑到良性病变可能,必要时建议病理或随访证实。

局限性

  • 回顾性单中心研究,样本量较小(44例),可能存在选择偏倚。
  • 未提供各系统病变的具体SUVmax、TBR数值及鉴别阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Although FAPI, as a pan-tumor tracer, shows high expression in the malignancy imaging, FAPI uptake is also seen in some benign lesions. The purpose of this study was to retrospectively analyze the characteristics of benign lesions with FAPI uptake on 68Ga-FAPI PET/CT imaging.

METHODS: The electronic medical and imaging records of patients undergoing 68Ga-FAPI PET/CT imaging in the Department of Nuclear Medicine of our hospital from March 2020 to March 2022 were retrospectively analyzed. Patients with benign lesions confirmed by histopathological analysis or long-term follow-up of FAPI-positive lesions were included in the study.

RESULTS: A total of 44 patients (i.e., 44 benign lesions) were included in this study, including 14 women and 30 men, ranging in age from 19 to 74 years. Benign lesions involved eight systems, including liver (n = 3), tail of pancreas (n = 3), stomach (n = 3), esophagus (n = 1), lung (n = 14), and mediastinum (n = 2), sinuses (n = 1), brain (n = 2), lymph nodes (n = 5), kidneys (n = 4), bones (n = 2), muscles (n = 1), thyroid (n = 1), parathyroid gland (n = 1), and breast (n = 1). The mean SUVmax (p = 0.471) and mean TBR (p = 0.830) of benign lesions in the eight systems were not significantly different.

CONCLUSION: Our studies have shown that in addition to malignant tumors, certain benign lesions also show uptake of FAPI, and it is necessary for doctors to distinguish these benign lesions from true malignant tumors.

ADVANCES IN KNOWLEDGE: Benign lesions may also show FAPI expression, which may make the differential diagnosis of benign and malignant lesions difficult and should be alerted by physicians.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Shu, Wang, Deng, et al. Benign lesions with 68Ga-FAPI uptake: a retrospective study. Br J Radiol. 2023. PMID: 36715164. doi:10.1259/bjr.20220994

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。